Cogent Biosciences, Inc.COGTNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P16
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -26.64% |
| Q3 2025 | -10.07% |
| Q2 2025 | -2.14% |
| Q1 2025 | -5.98% |
| Q4 2024 | 3.83% |
| Q3 2024 | -19.82% |
| Q2 2024 | -1.03% |
| Q1 2024 | -7.33% |
| Q4 2023 | 1.84% |
| Q3 2023 | -25.65% |
| Q2 2023 | -14.22% |
| Q1 2023 | 2.60% |
| Q4 2022 | -12.99% |
| Q3 2022 | -0.39% |
| Q2 2022 | -14.01% |
| Q1 2022 | -22.97% |
| Q4 2021 | -30.54% |
| Q3 2021 | -15.32% |
| Q2 2021 | -41.11% |
| Q1 2021 | -3.44% |
| Q4 2020 | 77.32% |
| Q3 2020 | -576.09% |
| Q2 2020 | -21.32% |
| Q1 2020 | -365.30% |
| Q4 2019 | 119.27% |
| Q3 2019 | -13.38% |
| Q2 2019 | 10.05% |
| Q1 2019 | -35.85% |
| Q4 2018 | 15.36% |
| Q3 2018 | -12.69% |
| Q2 2018 | -33.97% |
| Q1 2018 | -0.67% |
| Q4 2017 | 4.43% |
| Q3 2017 | -19.39% |
| Q2 2017 | 1.28% |
| Q1 2017 | 0.00% |
| Q3 2016 | 0.00% |
| Q3 2015 | 0.00% |